MAP3K7 C-terminal like" refers to a protein that shares homology with the C-terminal domain of the Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7), also known as TAK1. While the exact functions of the "MAP3K7 C-terminal like" protein may not be as well-characterized as MAP3K7 itself, it is presumed to have a role in signal transduction pathways related to cellular stress responses, inflammation, and apoptosis.
MAP3K7 is a serine/threonine kinase that acts as an upstream activator of several MAP kinase signaling cascades, including the NF-κB, JNK, and p38 MAP kinase pathways. These pathways are critical for the cellular response to cytokines, growth factors, and various stress stimuli. The C-terminal domain of MAP3K7 interacts with other proteins, including TAB1, TAB2, and TAB3, which are important for its activation and proper localization within the cell.Proteins with similarity to the C-terminal region of MAP3K7, like "MAP3K7 C-terminal like," could potentially interact with similar binding partners, hence influencing the same or parallel signaling pathways. By modulating these signaling cascades, "MAP3K7 C-terminal like" may play a pivotal role in regulating gene expression, cell differentiation, and survival.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ETC-159 | 1638250-96-0 | sc-507415 | 5 mg | $90.00 | ||
Dual TAK1/TRAF2 inhibitor, which may impact MAP3K7 C-terminal like activity by modulating TAK1 and TRAF2 pathways. | ||||||
Doramapimod | 285983-48-4 | sc-300502 sc-300502A sc-300502B | 25 mg 50 mg 100 mg | $149.00 $281.00 $459.00 | 2 | |
A potent p38 MAPK inhibitor, which might indirectly influence MAP3K7 C-terminal like by modulating the p38 MAPK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Another p38 MAPK inhibitor, potentially impacting MAP3K7 C-terminal like through the p38 MAPK axis. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
Similar to SB 203580, it inhibits p38 MAPK and may influence MAP3K7 C-terminal like activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, another MAP kinase, potentially influencing MAP3K7 C-terminal like indirectly. | ||||||